These findings support the role of AMPK suppression in promoting lipogenesis, insulin resistance, hepatic steatosis, and NAFLD (21, 81–84), highlighting the importance of AMPK/ACC signaling in metabolic regulation. Here, PRKAA2 is linked to Hepatic steatosis.